Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Vagus nerve stimulation therapy in Lennox-Gastaut syndrome (severe childhood epilepsy): plain language summary of a 2-year study.
Journal: Expert review of neurotherapeutics
Published: October 24, 2025
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the Expanded Access Program.
Journal: Epilepsia
Published: October 17, 2024
Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.
Journal: Epilepsia
Published: December 22, 2022
The direct cost of seizure events in severe childhood-onset epilepsies: A retrospective claims-based analysis.
Journal: Epilepsy & behavior : E&B
Published: November 15, 2018
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.
Journal: Epilepsia
Published: May 31, 2018
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Journal: Lancet (London, England)
Published: June 30, 2017
Showing 1-7 of 7
Last Updated: 09/26/2026